These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24462006)

  • 21. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
    Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY
    J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repetitive transarterial chemoembolization (rTACE) of hepatocellular carcinoma: comparisons between an arterial port system and conventional angiographic technique.
    Hidajat N; Griesshaber V; Hildebrandt B; Hosten N; Schröder RJ; Felix R
    Eur J Radiol; 2004 Jul; 51(1):6-11. PubMed ID: 15186878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization.
    Yu SC; Hui JW; Hui EP; Mo F; Lee PS; Wong J; Lee KF; Lai PB; Yeo W
    J Vasc Interv Radiol; 2009 Mar; 20(3):352-9. PubMed ID: 19167240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.
    Iwazawa J; Ohue S; Hashimoto N; Muramoto O; Mitani T
    Eur J Radiol; 2012 Dec; 81(12):3985-92. PubMed ID: 22959287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
    Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
    J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.
    Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS
    J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
    Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
    J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medico-economic study of the management of hepatocellular carcinoma by chemo-embolization.
    Clouet J; Audureau D; Lefranc B; Maillard N; Guilé R; Frampas E; Perret C; Grimandi G
    Diagn Interv Imaging; 2014 Apr; 95(4):427-34. PubMed ID: 24231346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
    Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
    J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.
    Takayasu K; Muramatsu Y; Maeda T; Iwata R; Furukawa H; Muramatsu Y; Moriyama N; Okusaka T; Okada S; Ueno H
    AJR Am J Roentgenol; 2001 Mar; 176(3):681-8. PubMed ID: 11222205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Conventional Transarterial Chemoembolization for Hepatocellular Carcinomas in Japan: Historical, Strategic, and Technical Review.
    Horikawa M; Miyayama S; Irie T; Kaji T; Arai Y
    AJR Am J Roentgenol; 2015 Oct; 205(4):764-73. PubMed ID: 26397324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
    Irie T; Kuramochi M; Takahashi N
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):706-13. PubMed ID: 22996589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
    Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
    Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma.
    Takayasu K; Arii S; Matsuo N; Yoshikawa M; Ryu M; Takasaki K; Sato M; Yamanaka N; Shimamura Y; Ohto M
    AJR Am J Roentgenol; 2000 Sep; 175(3):699-704. PubMed ID: 10954453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
    Cammà C; Schepis F; Orlando A; Albanese M; Shahied L; Trevisani F; Andreone P; Craxì A; Cottone M
    Radiology; 2002 Jul; 224(1):47-54. PubMed ID: 12091661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
    Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
    J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.